Clavis - La chiave del tuo benessere

Studi Scientifici sulla melatonina

Di seguito potete trovare l'elenco di alcuni studi selezionati da Clavis utili a capire le qualità della melatonina, i nostri informatori scientifici possono fornire a medici e farmacisti copia completa di alcuni degli studi indicati.

Melatonin and its brain metabolite n(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice
Víctor Tapias Molina, Germaine Escames Rosa, Luis Carlos López García, Ana López Ramírez, Dario Acuña Castroviejo - Journal Of Neuroscience Research - Doi: 10.1002/Jnr.22123

The Effect of Melatonin, Magnesium, and Zinc on Primary Insomnia in Long-Term Care Facility Residents in Italy: A Double-Blind, Placebo-Controlled Clinical Trial
Mariangela Rondanelli, PhD,Annalisa Opizzi,_Francesca Monteferrario, MD,_Neldo Antoniello, MD,Raffaele Manni, MD,and Catherine Klersy,  MDk. JAGS 59:82–90, 2011 r 2011, Copyright the Authors - Journal compilation r 2011, The American Geriatrics Society

Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy
Department of Biomedical Science and Biotechnology, Section of Human Anatomy, University of Brescia,.
Departement of Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, TX, USA

Efectos de la administración precoz de melatonina en pacientes críticos traumatizados
Effects of early melatonin administration on traumatized critical patients. M.D. Maldonado1, F. Murillo-Cabezas2, J.R. Calvo1. C. Med. Psicosom, Nº 89/90 – 2009

The Clinical Impact of Preoperative Melatonin on Postoperative Outcomes in Patients Undergoing Abdominal Hysterectomy
Anesthetic Pharmacology, Preclinical Pharmacology - Vol. 105, No. 5, November 2007

Endocrine regulation of the course of menopause by oral melatonin: first case report
Beatriz Lo´pez Dı´az, PhD,1 and Pla´cido Coto Llaneza, MD, PhD2. Menopause: The Journal of The North American Menopause Society. Vol. 15, No. 2, pp. 388/392

Evidencias de la utilidad de la melatonina frente aenvejecimiento y los procesos neurodegenerativos
D. Acuña-Castroviejo, G. Escames, L.C. López, F. Ortiz, A. López, J.A. García © Viguera Editores SL 2009. PSICOGERIATRÍA 2009; 1: 3-21

La melatonina reduce la respuesta de cortisol al ACTH en humanos
Carmen Campino, Francisco Valenzuela, Eugenio Arteaga, Claudia Torres-Faran, Cristian Trucco, Alfredo Velasco, Sergio Guzman. Melatonin reduces cortisol response to ACTH in humans

Therapeutic Effect of Melatonin in Experimental Uveitis
The American Journal of Pathology, Vol. 173, No. 6, December 2008

The role of melatonin in the neurodegenerative diseases
Olakowska E, Marcol W, Kotulska K, Lewin-Kowalik J - December 2008

Evidence of the usefulness of melatonin in ageing and neurodegenerative processes
D. Acuña-Castroviejo, G. Escames, L.C. López, F. Ortiz, A. López, J.A. García – 2008

Contribution of the daily melatonin profile to diagnosis of tumors of the pineal region
Received: 25 September 2008 / Accepted: 30 December 2008 - Springer Science+Business Media, LLC. 2009

Effect of melatonin in perimenopausal and menopausal woman: a randomized and placebo controlled study
G. Bellipanni, P. Bianchi, W. Pierpaoli, D. Bulian, E- Ilyia - 20 April 2000. Experimental Gerontology – Elsevier.

A Radiobiological Review on Melatonin: A Novel Radioprotector
Alireza SHIRAZI, Ghazaleh GHOBADI and Mahmoud GHAZI-KHANSARI
J. Radiat. Res., 48, 263-272 – 2007

Melatonin: Nature’s most versatile biological signal?
S. R. Pandi-Perumal, V. Srinivasan, G. J. M. Maestroni, D. P. Cardinali, B. Poeggeler
and R. Hardeland
FEBS Journal 273 (2006) 2813–2838 ª 2006 The Authors Journal compilation ª 2006 FEBS

 




NOTA BENE: Le informazioni presenti nelle schede prodotto che potrete consultare in questo sito non devono essere interpretate come consulenza medica e non intendono, né possono sostituire le prescrizioni mediche. Le informazioni in questo sito riguardano gli ingredienti contenuti negli integratori alimentari. Gli integratori non vanno intesi come mezzo per trattare, prevenire, diagnosticare o attenuare malattie o condizioni anomale.

CLAVIS SRL

Via Della Piazza 7/D
25127 Brescia ( BS )
Italy
DATI FISCALI

C.F./P.IVA/Reg. Impr. Brescia:
02391310980
( Verifica P.IVA )
REA 445872
Capitale Sociale Euro 12.000,00
CONTATTI

Telefono +39.030.3702608
Email: info@clavis2000.com
PEC: clavis@pecservice.it
NOTE LEGALI

Condizioni di vendita e
Privacy Policy

Cookies